257 related articles for article (PubMed ID: 25293656)
41. [Analysis of correlation between serum thymidine kinase 1 and acute myeloid leukemia].
Wang TJ; Sun AN; Wu DP; Li WY; Liang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1095-8. PubMed ID: 24156413
[TBL] [Abstract][Full Text] [Related]
42. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
43. Progesterone receptor membrane component 1 (PGRMC1) expression in canine mammary tumors: A preliminary study.
Terzaghi L; Banco B; Groppetti D; Dall'Acqua PC; Giudice C; Pecile A; Grieco V; Lodde V; Luciano AM
Res Vet Sci; 2020 Oct; 132():101-107. PubMed ID: 32544632
[TBL] [Abstract][Full Text] [Related]
44. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
45. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.
Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N
PeerJ; 2024; 12():e17077. PubMed ID: 38500523
[TBL] [Abstract][Full Text] [Related]
46. Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people.
Wang Y; Jiang X; Dong S; Shen J; Yu H; Zhou J; Li J; Ma H; He E; Skog S
Cancer Biomark; 2016 Mar; 16(4):529-36. PubMed ID: 27002755
[TBL] [Abstract][Full Text] [Related]
47. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
[TBL] [Abstract][Full Text] [Related]
48. Risk factor analysis and clinicopathological characteristics of female dogs with mammary tumours from a single-center retrospective study in Poland.
Dolka I; Czopowicz M; Stopka D; Wojtkowska A; Kaszak I; Sapierzyński R
Sci Rep; 2024 Mar; 14(1):5569. PubMed ID: 38448646
[TBL] [Abstract][Full Text] [Related]
49. AGR2-mediated unconventional secretion of 14-3-3ε and α-actinin-4, responsive to ER stress and autophagy, drives chemotaxis in canine mammary tumor cells.
Yuan SH; Wu CC; Wang YC; Chan XY; Chu HW; Yang Y; Liu HP
Cell Mol Biol Lett; 2024 May; 29(1):84. PubMed ID: 38822246
[TBL] [Abstract][Full Text] [Related]
50. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
[TBL] [Abstract][Full Text] [Related]
51. The overexpression of Hsp90B1 is associated with tumorigenesis of canine mammary glands.
Sunil Kumar BV; Bhardwaj R; Mahajan K; Kashyap N; Kumar A; Verma R
Mol Cell Biochem; 2018 Mar; 440(1-2):23-31. PubMed ID: 28801701
[TBL] [Abstract][Full Text] [Related]
52. [Application of serum thymidine kinase 1 of 26 055 cases in health screening for early detection of premalignant/early malignant tumors].
Cao X; Wang Y; Yang P; Zhou H; Liu C; Chen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 39(10):1029-34. PubMed ID: 25355255
[TBL] [Abstract][Full Text] [Related]
53. Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis.
Hussain S; Saxena S; Shrivastava S; Mohanty AK; Kumar S; Singh RJ; Kumar A; Wani SA; Gandham RK; Kumar N; Sharma AK; Tiwari AK; Singh RK
PLoS One; 2018; 13(12):e0208656. PubMed ID: 30517191
[TBL] [Abstract][Full Text] [Related]
54. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
55. Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors.
Im KS; Kim IH; Kim NH; Lim HY; Kim JH; Sur JH
Vet J; 2013 Mar; 195(3):366-72. PubMed ID: 22901454
[TBL] [Abstract][Full Text] [Related]
56. Over-expression of mammaglobin-B in canine mammary tumors.
Pandey M; Sunil Kumar BV; Gupta K; Sethi RS; Kumar A; Verma R
BMC Vet Res; 2018 Jun; 14(1):184. PubMed ID: 29903015
[TBL] [Abstract][Full Text] [Related]
57. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.
Manuali E; De Giuseppe A; Feliziani F; Forti K; Casciari C; Marchesi MC; Pacifico E; Pawłowski KM; Majchrzak K; Król M
BMC Vet Res; 2012 Jun; 8():86. PubMed ID: 22726603
[TBL] [Abstract][Full Text] [Related]
58. Aptamer-Based Sandwich Assay for Measurement of Thymidine Kinase 1 in Serum of Cancerous Patients.
Nazari M; Gargari SLM; Sahebghadam Lotfi A; Rassaee MJ; Taheri RA
Biochemistry; 2019 May; 58(18):2373-2383. PubMed ID: 30900869
[TBL] [Abstract][Full Text] [Related]
59. The half-life of thymidine kinase 1 in serum measured by ECL dot blot: a potential marker for monitoring the response to surgery of patients with gastric cancer.
Zou L; Zhang PG; Zou S; Li Y; He Q
Int J Biol Markers; 2002; 17(2):135-40. PubMed ID: 12113581
[TBL] [Abstract][Full Text] [Related]
60. Serum thymidine kinase activity: analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemia.
Szánthó E; Bhattoa HP; Csobán M; Antal-Szalmás P; Újfalusi A; Kappelmayer J; Hevessy Z
PLoS One; 2014; 9(3):e91647. PubMed ID: 24621590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
